Eli Lilly and Company
LLY · NEW YORK STOCK EXCHANGE, INC.
$1,417.99
+8.61 (+0.61%) today
+56.36% since Nov 4, 2025
Price 50-day average
- Open
- $1,440.00
- Day range
- $1,401.59 – $1,445.96
- 52-week range
- $850.51 – $1,449.68
- Volume
- 3.6M
Market data from Twelve Data and Finnhub. Prices may be delayed.
Industry
Pharmaceuticals
Market Cap
$1.33T
Recent News
Top story, explained
Log in to see the top story explained and predict how the stock reacted.
Eli Lilly Stocks Rise 2.32% While Revenue Guidance Faces a Quality-of-Growth Test
The latest quarter includes benefits that should be separated from underlying demand.
Yahoo · 11/4/2026
Novo’s Comeback Gets a Pill-Shaped Boost as Wegovy Starts to Bite Back
Novo Nordisk finally has some momentum again. Its Wegovy pill is selling faster than expected, lifting the company’s outlook and giving the Danish drugmaker a credible route back into an obesity market that Eli Lilly has spent the past two years making its own.
Yahoo · 11/4/2026
National Advertising Division Recommends Good Life Discontinue Health Benefit and Personalization Claims for Compounded Tirzepatide+ Products
In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Good Life Meds, LLC discontinue the challenged express health benefit and personalization claims for its compounded Tirzepatide+ products and modify its advertising to avoid conveying unsupported implied claims about product safety, efficacy, weight loss results, and personalization.New York, NY, Nov. 04, 2026 (GLOBE NEWSWIRE) -- In a challenge brought by Eli Lilly and Company,
Yahoo · 11/4/2026
Biopharma stocks climb on Merck and Eli Lilly earnings
CNBC · 10/29/2026
Practice Trade
Estimated cost: $1417.99